Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Angina IV: Management01:26

Angina IV: Management

410
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
410
Angina II: Classification01:27

Angina II: Classification

561
Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
561
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

436
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
436
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

545
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
545
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

398
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
398
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

619
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
619

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Vaccination saves lives: a real-time study of patients with chronic diseases and severe COVID-19 infection.

QJM : monthly journal of the Association of Physicians·2022
Same author

Building Capacity for Evidence-Informed Priority Setting in the Indian Health System: An International Collaborative Experience.

Health policy OPEN·2021
Same author

Clinical and angiographic profiles and six months outcomes of smokers with acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary angioplasty.

Indian heart journal·2018
Same author

Authors' response.

The Indian journal of medical research·2016
Same author

Saphenous vein graft interventions: strategies and devices to minimize distal embolization.

Minerva cardioangiologica·2012
Same author

Pi--from the Greeks to the cardiologists: the pi sign- aberrant OM from LAD.

Indian heart journal·2011

相关实验视频

Updated: Mar 23, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

9.2K

血管造形术后的冠心内马辐射疗法抑制了静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静

R Waksman1, R L White, R C Chan

  • 1Cardiology Research Foundation, Division of Cardiology, Washington Hospital Center, Washington DC 20010, USA.

Circulation
|May 10, 2000
PubMed
概括

冠内马辐射疗法显著减少了静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉. 这种治疗减少了对静脉复苏和二进制血管静脉复缩的需要,在患者内置静脉复缩.

更多相关视频

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.8K
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

26.5K

相关实验视频

Last Updated: Mar 23, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

9.2K
Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.8K
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

26.5K

科学领域:

  • 心脏病学 心脏病学
  • 干预心脏病学 干预心脏病学
  • 辐射瘤学 辐射瘤学

背景情况:

  • 静脉支架静止症是冠状动脉支架植入的一个重要并发症.
  • 电离辐射在减少支架内的新极端增生症方面表现有前途.
  • 之前在动物模型和早期临床试验中进行的研究表明,放射治疗有好处.

研究的目的:

  • 与安慰剂相比,评估冠心内马辐射治疗的疗效.
  • 评估对患者的临床和血管学结局的影响.

主要方法:

  • 一项随机,双盲研究,涉及130名患有静脉支架置症的患者.
  • 在冠状动脉干预成功后,患者接受了冠状动脉内马辐射 (192Ir,15Gy) 或安慰剂.
  • 血管造影和血管内超声波的终点被盲目的核心实验室分析.

主要成果:

  • 在6个月后,照射组与安慰剂 (P<0.0001) 相比,显著降低了目标损伤再血管化率 (13.8%vs. 63.1%) 和目标血管再血管化率 (26.2%vs. 67.7%).
  • 在照射组中,二进制血管图形静止症显著减少 (19%对比58%,P=0.001).
  • 在放射治疗组中,免受主要心脏不良事件的影响较低 (29.2%对67.7%,P<0.001).

结论:

  • 作为辅助疗法的冠内射马辐射有效地减少了在静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉.
  • 这些发现支持使用放射治疗来改善这种患者群体的治疗结果.